- $7.73bn
- $7.50bn
- $914.52m
- 98
- 17
- 95
- 81
Annual balance sheet for Cognex, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 372 | 324 | 400 | 332 | 246 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 133 | 137 | 131 | 120 | 151 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 602 | 640 | 718 | 679 | 613 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 102 | 101 | 117 | 181 | 166 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,801 | 2,004 | 1,958 | 2,018 | 1,993 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 132 | 189 | 188 | 152 | 169 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 539 | 574 | 520 | 513 | 475 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 1,262 | 1,430 | 1,438 | 1,505 | 1,518 |
| Total Liabilities & Shareholders' Equity | 1,801 | 2,004 | 1,958 | 2,018 | 1,993 |
| Total Common Shares Outstanding |